75
Participants
Start Date
May 31, 2007
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2011
Cardioblate System Surgical Ablation System
This investigation is a prospective, nonrandomized multicenter clinical trial evaluating the outcome of patients with AF requiring concomitant open heart surgery plus the Cardioblate Surgical Ablation System using the modified Maze III procedure. The trial population includes patients requiring valve replacements or repairs, atrial septal defect (ASD) repairs, patent foramen ovale (PFO) closure or coronary artery bypass grafts (CABG) procedures.
Surgical RF Ablation
This investigation is a prospective, nonrandomized multicenter clinical trial evaluating the outcome of patients with AF requiring concomitant open heart surgery plus the Cardioblate Surgical Ablation System using the modified Maze III procedure. The trial population includes patients requiring valve replacements or repairs, atrial septal defect (ASD) repairs, patent foramen ovale (PFO) closure or coronary artery bypass grafts (CABG) procedures.
Lenox Hill Hospital, New York
Hospital of University of Pennsylvania, Philadelphia
Inova Fairfax, Falls Church
Cardiac Surgical Associates of Florida, St. Petersburg
Cleveland Clinic Foundation, Cleveland
Aurora St. Luke's Medical Center, Milwaukee
Mayo/St. Mary's Hospital, Rochester
Northwestern Memorial Hospital, Chicago
Washington University School of Medicine, St Louis
Southwest Heart and Lung, Phoenix
New Mexico Heart Institute, Albuquerque
University of Southern California, Los Angeles
Eisenhower Medical Center, Palm Springs
East Bay Cardiovascular & Thoracic Associates, Concord
Englewood Hospital and Medical Center, Englewood
Lead Sponsor
Medtronic Cardiovascular
INDUSTRY